Effect of biogenic amines on gamma-amylase (acid alpha-glucosidase).
D000681:Amylases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005959:Glucosidases / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D007490:Iproniazid / Q000494:pharmacology; D008099:Liver / Q000187:drug effects; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D014363:Tryptamines / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology*
D002395:Catecholamines; D014363:Tryptamines; D010293:Pargyline; D007490:Iproniazid; D000681:Amylases; D005959:Glucosidases; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine